BiomeAI

BiomeAI

LAUNCHING
Agent
Gut Health
$BIOMEAI

BiomeAI is a cutting-edge health assistant powered by over 1,000 rigorously curated scientific studies on microbiome science and real-world experiments, designed to help people make smarter, personalized health choices with trustworthy data as its foundation. Built and advised by a team of top experts in gut health and AI, BiomeAI blends deep scientific credibility with participatory governance model to let users test, learn, and figure out what works for them. Every experiment and health insight feeds into a transparent, collective knowledge base that grows with you and the active community. Holding $BIOMEAI grants exclusive first access to the most validated N=10 trial protocols and the next big gut health breakthrough. Top yappers and traders gain a winning chance to earn free microbiome tests by completing community missions, turning engagement into tangible health value.

...
Community Size
...
Growth Rate
BiomeAI

Community Sentiment

How do you feel about this agent?

...
No trend data

1. Pledging BioXP

Your final token allocation is determined by your BioXP pledge relative to the total BioXP pledged by other participants.

Over-pledging increases your chances of obtaining the max allocation (0.5% of the total supply).

If the launch succeeds, only the BioXP used for your final allocation are burnt, and you are refunded the rest.

2. Committing $BIO

The $BIO you commit during the fundraising will be used to purchase your final token allocation.

The price of the token is fix (1 $BIO = X $AGENT).

3. Claiming your tokens

Once the launch has succeeded, claim your purchased tokens on this page (check the Community Announcements).

Any refunded $BIO will be claimable in your Portfolio page.

1
Pledge BioXP
BioXP
Your Balance()
0 BioXP
2
Commit $BIO
BIO
$0.00
Suggested $BIO to commit
Your Balance()
0 $BIO
Community
Feed
...
Announcements

No announcements yet

Come back at a later point

Tokenomics

10,000,000

Total Supply
Ignition Sale
40%
Liquidity
6.86%
Concentrated Liquidity
10%
Treasury
35%
Founders
5%
Bio Protocol
3.14%
Ignition Sale
Liquidity
Concentrated Liquidity
Treasury
Founders
Bio Protocol
Loading chart...
Project

Katya Kostyuchenko

Marketing & Community Growth

Robin Lehmann

Lead Developer & AI Architect

Kishore Kumar

Product development & Business strategy

Kiran Krishnan

Advisor - Serial Entrepreneur at EndoAxis LLC, MicrobiomeLabs, Compelling Natural Health

Avimanyu Bandyopadhyay

Founder & Computer Scientist - Creator of DeSciOS at Avimanyu Innovations, Lead Organizer of DeSci India & DeSci Kolkata

Dr. Maria Corliano

Gut Microbiome Expert - Lead Grant Analyst at Longevity Science Foundation

Mike Ananyin Fonseca

Advisor - State Solutions Architect & Digital Governance Expert at WeRa Global

Q3 2025

BETA LAUNCH - Discord, X, and Web app for early adopters with beta testing access

BIOMEAI AGENT WEBSITE - Privacy-compliant platform for PII data handling and user onboarding

HYPOTHESIS ENGINE - N=10 trials system to validate research ideas and protocols faster

DATA INTEGRATION - Seamless uploads from major microbiome labs with automated processing

BIOMEKEYS RAFFLE SYSTEM - Monthly Raffle, Raffle tickets and BiomeKey passes for community

Q4 2025

PRIVACY LLM DEPLOYMENT - Privacy-preserving AI for secure health data analysis

KNOWLEDGE GRAPH LIVE - Production deployment of community knowledge graphs

P.O.O.P AGENT INTEGRATION - Personalized protocol optimization with habit tracking and daily updates

EXPANDED AI TRAINING - Scale to 10,000+ studies for robust health insights and recommendations

SEMI-AUTONOMOUS AGENT - Transaction autonomy with Base AgentKit integration for wallet operations

Q1 2026

MULTI-AGENT LAB - AI co-scientists driving autonomous discovery and research collaboration

DATA-FOR-SCIENCE MARKETPLACE - Pay-to-compute reuse of anonymized datasets for research monetization

Market Overview

$50 Billion
Annual IBD costs in the US; similar burdens exist in EU/Asia. $13,288 median annual healthcare cost per IBS, Crohn’s disease, and ulceritis patient in the US.
$196 Billion
Projected market size by 2030 for probiotics, live biotherapeutics, and multi-omic diagnostics, with an annual growth rate of 14%.
>$1 Billion
Valuation of 180+ microbiome therapies currently progressing through clinical trials, highlighting an urgent demand for rich longitudinal datasets and innovative trial methodologies.

Problem

Conventional health apps treat everyone the same, pushing generic advice, rigid menus, and analytics that don’t account for your unique gut microbiome or lifestyle. They can’t help you test new habits tailored to your gut health or explain why a tip should work, leaving you stuck guessing through daily issues driven by your individual microbiome makeup.

Result: You're stuck with generic health advice that doesn't fit your gut or your life, backed by explanations you can't verify.

Solution: The N=10 Revolution

BiomeAI introduces collaborative gut health discovery through our innovative N=10 model: BiomeAI lets you log what matters to your gut and overall lifestyle, try different routines, and team up with others sharing similar microbiome profiles and goals. The AI agent spots patterns specific to your gut health group on how foods, supplements, or habits affect outcomes like digestion, immunity, energy, and even mental focus and shows you the proof with data you can verify.

Hypothesis/Impact:

When everyday people experiment and share real gut health experiences alongside expert data, BiomeAI’s N=10 model unlocks health solutions uniquely tailored to your personal microbiome. As a result, you get real, replicable results thus making your health choices proactive, evidence-based, and uniquely yours.

Stay up to date

Get the latest community updates and find out about upcoming BiomeAI developments